:: Class Utilisation Summary 2016
See LEGEND for key to shading and symbols.
:: Subject Area - OPTM Term - Semester 2
| OPTM0001 | OPTM0002 | OPTM2291 | OPTM3211 | OPTM3231 | OPTM4211 |
| OPTM4231 | OPTM4251 | OPTM4271 | OPTM5211 | OPTM5231 | OPTM5251 |
| OPTM5271 | OPTM7001 | OPTM7003 | OPTM7007 | OPTM7104 | OPTM7108 |
| OPTM7117 | OPTM7203 | OPTM7205 | OPTM7308 |
Data is correct as at Tue Oct 11 19:05:29 AEDT 2016
| Comp | Sect | Class | Type | Status | Enr/Cap | % Full | Times (weeks, Location) - default 1hour |
| OPTM0001 | Research Thesis Optometry F/T | ||||||
| THE | 0001 | 1225 | Enr | Open | 28/2000 | 1% | |
| OPTM0002 | Research Thesis Optometry P/T | ||||||
| THE | 0001 | 1226 | Enr | Open | 9/2000 | 0% | |
| OPTM2291 | Primary Care Optometry | ||||||
| LAB | GP1 | 7347 | Enr | Open | 21/22 | 95% | Mon 09-11 (w2-9,10-13, Myers 2009); Tue 08 (w10-13, Myers 2009); Wed 14-16 (w2-9,10-13, Myers 2009) |
| LAB | GP2 | 7348 | Enr | Open | 19/21 | 90% | Mon 14-16 (w2-9,10-13, Myers 2009); Thu 08 (w10-13, Myers 2009); Thu 12-14 (w2-9,10-13, Myers 2009) |
| LAB | GP3 | 7349 | Enr | Open | 9/22 | 41% | Mon 16-18 (w2-9,10-13, Myers 2009); Wed 08 (w10-13, Myers 2009); Thu 14-16 (w2-9,10-13, Myers 2009) |
| LAB | GP4 | 7350 | Enr | Full | 22/22 | 100% | Tue 11 (w10-13, Myers 2009); Tue 12-14 (w2-9,10-13, Myers 2009); Thu 16-18 (w2-9,10-13, Myers 2009) |
| LAB | GP5 | 7351 | Enr | Open | 21/22 | 95% | Wed 10-12 (w2-9,10-13, Myers 2009); Fri 08 (w10-13, Myers 2009); Fri 10-12 (w2-9,10-13, Myers 2009) |
| LEC | A | 7345 | Rel | Open | 92/105 | 88% | Mon 11 (w1-4,5,6,7,8-9,10,11,12, OMB G31); Fri 09 (w1,2,3,5-9,10,11,12, Myers Thtr); Fri 09 (w4, Myers Thtr) |
| OTH | H09A | 7346 | Rel | Open | 92/105 | 88% | Thu 09-12# (Myers 2030) |
| OPTM3211 | Optometry 3B | ||||||
| LA1 | GP1 | 4435 | Enr | Stop | 21/22 | 95% | Mon 10-12 (w1-9,11-13, Myers Thtr); Mon 12 (w1-9,11-13, See School); Tue 08-10 (w7-9, Myers 2009) |
| LA1 | GP2 | 4436 | Enr | Open | 19/22 | 86% | Mon 10-12 (w1-9,11-13, Myers Thtr); Mon 12 (w1-9,11-13, See School); Wed 12-14 (w7-9, Myers 2009) |
| LA1 | GP3 | 4437 | Enr | Full | 23/22 | 100% | Tue 13-15 (w1-9,11-13, Myers Thtr); Tue 15 (w1-9,11-13, See School); Wed 08-10 (w7-9, Myers 2009) |
| LA1 | GP4 | 4438 | Enr | Full | 24/22 | 100% | Tue 13-15 (w1-9,11-13, Myers Thtr); Tue 15 (w1-9,11-13, See School); Fri 08-10 (w7-9, Myers 2009) |
| LA1 | GP5 | 4439 | Enr | Stop | 0/22 | 0% | Tue 10-12 (w7-9, Myers 2009) |
| LA2 | AQUA | 4440 | Rel | Stop | 11/11 | 100% | Tue 11 (w2-9,10-13, Myers 3016) |
| LA2 | BLUE | 4441 | Rel | Open | 9/11 | 82% | Tue 13 (w2-9,10-13, Myers 3016) |
| LA2 | GREE | 4442 | Rel | Stop | 11/11 | 100% | Wed 10 (w2-9,10-13, Myers 3016) |
| LA2 | GREY | 4443 | Rel | Closed | 0/11 | 0% | Wed 09 (w2-9,10-13) |
| LA2 | ORAN | 4444 | Rel | Open | 7/11 | 64% | Wed 11 (w2-9,10-13, Myers 3016) |
| LA2 | PURP | 4445 | Rel | Open | 10/11 | 91% | Fri 12 (w2-9,10-13, Myers 3016) |
| LA2 | RED | 4446 | Rel | Stop | 6/11 | 55% | Tue 09 (w2-9,10-13, Myers 3016) |
| LA2 | TAN | 4447 | Rel | Stop | 11/11 | 100% | Thu 09 (w2-9,10-13, Myers 3016) |
| LA2 | VIOL | 4448 | Rel | Stop | 11/11 | 100% | Thu 10 (w2-9,10-13, Myers 3016) |
| LA2 | YELL | 4449 | Rel | Stop | 11/11 | 100% | Tue 10 (w2-9,10-13, Myers 3016) |
| LEC | A | 4434 | Rel | Open | 87/110 | 79% | Thu 11 (w1-9,10-12, MathewsThD); Fri 10-12 (w1-9,10,11, MathewsThD); Fri 10-12 (w12, MathewsThD) |
| OPTM3231 | Ocular Disease 3B | ||||||
| LEC | M15A | 4450 | Enr | Open | 100/114 | 88% | Mon 15-17 (w2-9,10-13, RC Theatre); Tue 16-18 (w2-9,10-13, CivEng 101); Thu 12 (w2-9,10-13, Myers Thtr) |
| OPTM4211 | Optometry 4B | ||||||
| LA1 | F12A | 4453 | Enr | Open | 21/22 | 95% | Fri 12-14 (w2-4,8,10-13, Myers 2009); Fri 12-14 (w5-7,9, Myers 2009) |
| LA1 | F16A | 4455 | Enr | Canc | 0/20 | 0% | Fri 16-18 (w2-4,8,10-13); Fri 16-18 (w5-7,9) |
| LA1 | M11A | 4452 | Enr | Open | 19/20 | 95% | Mon 11-13 (w2-4,8,10-13, Myers 2009); Mon 11-13 (w5-7,9, Myers 2009) |
| LA1 | W16A | 4454 | Enr | Open | 20/21 | 95% | Wed 16-18 (w2-4,8,10-13, Myers 2009); Wed 16-18 (w5-7,9, Myers 2009) |
| LA2 | T10A | 4457 | Rel | Open | 22/24 | 92% | Tue 10-12 (w2-3, OMB G25); Tue 10-12 (w5, Myers 2030) |
| LA2 | T10B | 4458 | Rel | Open | 19/24 | 79% | Tue 10-12 (w6-7, OMB G25); Tue 10-12 (w8, Myers 2030) |
| LA2 | T13A | 4456 | Rel | Open | 19/24 | 79% | Tue 13-15 (w2-3, OMB G25); Tue 13-15 (w5, Myers 2030) |
| LEC | A | 4451 | Rel | Open | 60/65 | 92% | Mon 16 (w1, Myers Thtr); Mon 16 (w2-4, Myers Thtr); Tue 16-18 (w1-9, Myers Thtr); Tue 16-18 (w10-12, Myers Thtr); Thu 16 (w1,5-7, Myers Thtr); Thu 16 (w2-4, Myers Thtr); Thu 16 (w8,10,12, Myers Thtr); Thu 16 (w9,11, Myers Thtr); Thu 17 (w1-4,5-7, Myers Thtr); Thu 17 (w8-9,10-12, Myers Thtr); Fri 10 (w1-4, Myers Thtr) |
| OPTM4231 | Clinical Optometry 4B | ||||||
| LEC | A | 4464 | Enr | Open | 62/68 | 91% | Mon 17 (w2-9,10-13, Myers Thtr); Fri 11 (w2-9,10-13, Myers Thtr) |
| OPTM4251 | Ocular Therapeutics 4B | ||||||
| LAB | 501 | 4460 | Enr | Open | 17/18 | 94% | Fri 09-11 (w8-9,10-12, OPTM CL) |
| LAB | 502 | 4461 | Enr | Open | 17/18 | 94% | Mon 11-13 (w8-9,10-12, OPTM CL) |
| LAB | 503 | 4462 | Enr | Open | 16/18 | 89% | Tue 14-16 (w8-9,10-12, OPTM CL) |
| LAB | 504 | 4463 | Enr | Open | 17/18 | 94% | Fri 14-16 (w8-9,10-12, OPTM CL) |
| LEC | A | 4459 | Rel | Full | 67/67 | 100% | Mon 09-11 (w2-9,10-13, TETB LG07) |
| OPTM4271 | Professional Optometry | ||||||
| LEC | A | 6068 | Enr | Full | 65/65 | 100% | Mon 14-16 (w2-9,10-13, Myers Thtr); Thu 14-16 (w2-9,10-13, Myers Thtr) |
| OPTM5211 | Clinical Optometry 5B | ||||||
| LEC | A | 4465 | Enr | Open | 45/47 | 96% | Mon 17 (w2-9,10-13, Myers Thtr); Fri 13 (w2-9,10-13, Myers Thtr) |
| OPTM5231 | Specialist Clinical Optom 5B | ||||||
| TUT | A | 4466 | Enr | Open | 45/47 | 96% | Tue 15:30 (w2-9,10-13, Myers 2030) |
| OPTM5251 | Clinical Ocular Therap 5B | ||||||
| CLN | 001 | 9502 | Enr | Open | 45/47 | 96% | |
| OPTM5271 | Research Project 5B | ||||||
| OTH | 001 | 9503 | Enr | Open | 46/47 | 98% | |
| OPTM7001 | Intro to Community Eye Health | ||||||
| LEC | 001 | 9893 | Enr | Open | 9/15 | 60% | |
| OPTM7003 | Epid of Blinding Eye Diseases | ||||||
| LEC | 001 | 9894 | Enr | Open | 4/15 | 27% | |
| OPTM7007 | Community Eye Health Project | ||||||
| LEC | 001 | 9897 | Enr | Open | 0/10 | 0% | |
| OPTM7104 | Adv. Contact Lens Studies 1 | ||||||
| LEC | 001 | 10235 | Enr | Open* | 5/30 | 17% | |
| OPTM7108 | Research Skills in Optometry | ||||||
| LEC | 001 | 9895 | Enr | Open | 4/30 | 13% | |
| OPTM7117 | Ocular Therapy 2 | ||||||
| LEC | 001 | 10129 | Enr | Open | 22/30 | 73% | |
| OPTM7203 | Behavioural Optometry 2 | ||||||
| LEC | 001 | 9892 | Enr | Open | 10/30 | 33% | |
| OPTM7205 | Specialty Contact Lens Studies | ||||||
| LEC | 001 | 9889 | Enr | Open | 6/15 | 40% | |
| OPTM7308 | Research Project | ||||||
| LEC | 001 | 9896 | Enr | Open | 5/30 | 17% | |
| ^ top ^ | |||||||
| LEGEND | |||||||
| * This class requires consent. Students cannot self-enrol. | |||||||
| # Timetable clash allowed. | |||||||
| /odd Runs in odd weeks only. /even Runs in even weeks only. | |||||||
| Comb/w Jointly taught with corresponding class(es) for specified course(s). Capacity shown is effective capacity. | |||||||
| Effective capacity is the class capacity less any places taken by students in the other jointly-taught classes. | |||||||
| [ ] Class capacity where different from effective capacity. | |||||||
| Shaded cells: | LEC | Activity different from previous | |||||
| Stop | Status is Stop Further Enrolment, Tentative, Closed or Cancelled | ||||||
| 100% | Class is full (> 100% means capacity is exceeded) | ||||||
| 80% | Class is nearly full (80% or more) | ||||||
| 50% | Class is half full | ||||||
| 0% | Class is less than half full | ||||||
| UNSW Sydney NSW 2052, Australian Telephone: (within Aust) 02 9385 1000, (International) +61 2 9385 1000 CRICOS Provider Code 00098G • Authorised by Deputy Vice Chancellor (Academic) & Registrar • Privacy Statement • Copyright & Disclaimer |